IDH2 and cancer: While most IDH-mutant DGs harbor the common arginine-to-histidine mutation at codon 132 (p.R132H), approximately 10% of cases exhibit non-canonical IDH mutations, characterized by distinct radiological and histological features and a potential association with cancer predisposition genes [10].